FDA — authorised 8 June 2006
- Application: NDA021254
- Marketing authorisation holder: GLAXO GRP LTD
- Local brand name: ADVAIR HFA
- Indication: AEROSOL, METERED — INHALATION
- Status: approved
🇺🇸 Advair HFA in United States
FDA authorised Advair HFA on 8 June 2006
Marketing authorisation
Other Respiratory/Pulmonology approved in United States
Frequently asked questions
Is Advair HFA approved in United States?
Yes. FDA authorised it on 8 June 2006.
Who is the marketing authorisation holder for Advair HFA in United States?
GLAXO GRP LTD holds the US marketing authorisation.